A Case of Pulmonary Cryptococcosis After Severe COVID-19 Pneumonia

Roesch, T.; Altneu, E.; Müeller, Daniel J.

doi:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5449

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the same year, Roesch and collaborators [59] reported a case of a female patient, where conventional results did not detect the presence of comorbidities. Pathology demonstrated a collection of histiocytes, neutrophils, and necrotic debris, and pathology stains were positive for Cryptococcus fungal organisms, leading to a secondary lung cryptococcal infection.…”

Section: Reports Of Immunosuppression In Cases Of Sars-covmentioning

confidence: 98%

Challenges of the Global COVID-19 Pandemic and Invasive Fungal Pathogens in SARS-COV-2 Associations: A Dangerous Relationship

Mariscal¹,

Matias²,

Almeida³

et al. 2023

AiM

View full text Add to dashboard Cite

Background: COVID-19 is a rapidly transmissible pneumonia-like illness caused by SARS-CoV-2 that out broke in China in 2019 and is currently circulating worldwide. In the current context of the SARS-CoV-2 pandemic, complications are observed in clinical settings for the treatment of severe COVID-19 disease in nosocomial settings, due to cases of fungal co-infections. Objective: To carry out a review on fungal infections associated with respiratory infections caused by COVID-19 (Sars-Cov-2) and their aggravation. Methodology: The purpose of this study is to inform the reader about the characteristics of SARS-CoV-2 and the main fungal species that are affecting patients undergoing treatment for severe COVID-19, provoking discussion of the importance of the proposed topic, in relation to co-infections by different fungal microorganisms. Result: 80 scientific studies were selected, resulting from patients with COVID-19 and most commonly observed in patients with a history of comorbidities such as diabetes mellitus, hypertension, kidney disease, severe liver disease, oncological diseases, obesity and with severe COVID-19. These data do not represent the total number of records of the disease in the world, but cases reported by researchers in their series, showing the overlapping of fungal co-infection through the compromised immune status due to the use of therapeutic drugs, dysregulation of the microbiota, How to cite this paper: Mariscal, A.

show abstract

Section: Reports Of Immunosuppression In Cases Of Sars-covmentioning

confidence: 98%